Hydroxyapatite is treated by a combination of nitridation and the
application of bone morphogenetic protein or DNA encoding such a protein
to improve the tissue compatibility and affinity of the hydroxyapatite,
rendering the hydroxyapatite more useful as a material for biomedical
implants.